Article
Association between PD-L1 expression and driver gene mutations in non-small cell lung cancer patients: correlation with clinical data.
Virchows Archiv : an international journal of pathology - 1 Aug 2020
Karatrasoglou Eleni A, Chatziandreou Ilenia, Sakellariou Stratigoula, Stamopoulos Konstantinos, Kavantzas Nikolaos, Lazaris Andreas C, Korkolopoulou Penelope, Saetta Angelica A
Abstract excerpt
Lung cancer is the leading cause of cancer death worldwide. Recently, promising therapies have emerged based on PD-1/PD-L1 immune checkpoint inhibitors, which have been approved even as frontline treatment for patients with non-small cell lung cancer (NSCLC). We examined the association between PD-L1 expression and clinicopathological parameters as well as overall survival in 220 NSCLC patients. PD-L1 expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.